Clinical Trial Update: add-on Low Dose Memantine in Middle-to-old Aged Bipolar II Disorder Patients [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial investigating add-on low-dose memantine for bipolar II disorder in middle-to-older adults, spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Ii Disorder

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Bipolar II Disorder | Phase 2, Phase 3 | Status: UNKNOWN